Midea Strengthens Global Presence in the Heat Pump Industry with Optimistic Market Outlook
FOSHAN, China, Dec. 13, 2024 /PRNewswire/ -- In a recent exclusive interview with JARN, a leading Japanese HVAC industry publication, Peter Guan, Vice President of Midea Group and President of Midea Building Technologies (MBT), shared insights into...
WeBank Recognized on CNBC Best Banks Asia-Pacific 2024
SHENZHEN, China, Dec. 13, 2024 /PRNewswire/ -- Recognized for its resilience, adaptability, trustworthiness and reliability, WeBank is selected to the CNBC 2024 list of the Best Banks Asia-Pacific in China. In the first edition of the list, CNBC...
Putting a "green scarf" around the Taklimakan Desert
BEIJING, Dec. 13, 2024 /PRNewswire/ -- A news report from China.org.cn on China's efforts on combating desertification: Putting a “green scarf” around the Taklimakan Desert "Sandy wind, is blowing over the shed… Sheep in the pen, are circling...
VVR Advances Global Expansion with Finland's EAF Certification and Partnerships in the XR/VR Education Market
- VVR achieves EAF (Education Alliance Finland) Certification following Helsinki Ministry of Education Testbed Program collaboration - It strengthens presence in global IT education markets, including Japan, Mongolia, and India SEOUL, South Korea,...
Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong
92% Diagnostic Accuracy with a Simple Blood Test for Early Diagnosis and Treatment of Endometriosis HONG KONG, Dec. 13, 2024 /PRNewswire/ -- Heranova, a leader in women's health innovation, is excited to announce the launch of HerResolve™, a...
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS
PRINCETON, N.J. and SUZHOU, China, Dec. 13, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and...
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK,...
IBM and State of Illinois to Build National Quantum Algorithm Center in Chicago with Universities and Industries
Anchored by next-generation IBM Quantum System Two in Illinois Quantum and Microelectronics Park, new initiative will advance useful quantum applications as industries move towards quantum-centric supercomputing YORKTOWN HEIGHTS, N.Y. and CHICAGO,...